# Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pudendal Neuralgia

> **NCT06644261** · PHASE4 · RECRUITING · sponsor: **University of Louisville** · enrollment: 40 (estimated)

## Conditions studied

- Pudendal Neuralgia
- Chronic Pelvic Pain Syndrome

## Interventions

- **DRUG:** Bupivacaine injection

## Key facts

- **NCT ID:** NCT06644261
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-27
- **Primary completion:** 2025-07-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06644261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06644261, "Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pudendal Neuralgia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06644261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*